Related Experiment Videos
Paraneoplastic neuromuscular syndromes
1Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Neurologic Clinics
|August 1, 1997
Summary
Paraneoplastic syndromes, though rare, significantly impact neuromuscular function, often linked to small-cell lung cancer. Early cancer treatment can lead to improvements in these debilitating neurological conditions.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Paraneoplastic syndromes are rare autoimmune disorders triggered by cancer.
- Neuromuscular manifestations are a significant concern in paraneoplastic syndromes.
- Small-cell lung cancer is the most frequently associated malignancy.
Purpose of the Study:
- To review well-defined neuromuscular paraneoplastic syndromes.
- To discuss the pathophysiology and clinical features of these syndromes.
- To highlight the association with various malignancies, particularly small-cell lung cancer.
Main Methods:
- Literature review of neuromuscular paraneoplastic syndromes.
- Discussion of pathophysiology and clinical presentations.
- Categorization of syndromes including Lambert-Eaton myasthenic syndrome, motor neuron disorders, peripheral neuropathies, and continuous muscle fiber disorders.
Main Results:
- Neuromuscular paraneoplastic syndromes share common features: concurrent malignancy, rapid progression, and severe disability.
- Treatment of the underlying cancer offers potential for clinical improvement.
- Specific syndromes discussed include Lambert-Eaton myasthenic syndrome, motor neuron disorders, peripheral neuropathies, and Stiffman syndrome.
Conclusions:
- Neuromuscular paraneoplastic syndromes require prompt diagnosis and management of the associated malignancy.
- Understanding the pathophysiology is crucial for effective treatment strategies.
- Early intervention targeting the cancer can mitigate neurological deficits and improve patient outcomes.